Related Experiment Video
Updated: Jul 18, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Synergism between apple procyanidins and lysosomotropic drugs: potential in chemoprevention
Nikolaus Seiler1, Mehdi Chaabi, Stamatiki Roussi
1INSERM U682, Laboratory of Nutritional Cancer Prevention, IRCAD, 67091 Strasbourg, France. nikolaus.seiler@ircad.u-strasbg.fr
Background:
Procyanidins are apple constituents with potential in colon cancer chemoprevention.
Materials And Methods:
Human colon cancer derived metastatic cells (SW620), growing under standardized conditions, were exposed to procyanidins and lysosomotropic compounds. Growth, apoptosis and lysosomal integrity was determined using published methods.
Results:
Lysosomotropic drugs (MDL 72527, phenylalanine methylester and chloroquine) amplified procyanidin-induced growth inhibition and apoptosis in SW620 cells at non-cytotoxic concentrations. The improved toxicity of the drug combinations relies primarily on the enhancement of lysosomal membrane permeability.
Conclusion:
Combinations with non-toxic concentrations of lysosomotropic compounds improve the anti-carcinogenic properties of apple procyanidins.
Insights
Apple procyanidins show promise for colon cancer prevention. Combining them with lysosomotropic compounds enhances their anti-cancer effects by improving lysosomal function.
Area of Science:
- Oncology
- Pharmacology
- Nutraceuticals
Background:
- Procyanidins, found in apples, are investigated for their potential role in colon cancer chemoprevention.
- Colon cancer remains a significant health concern, necessitating novel chemopreventive strategies.
Purpose of the Study:
- To evaluate the synergistic effects of apple procyanidins and lysosomotropic compounds on colon cancer cells.
- To determine the impact of these combinations on cancer cell growth, apoptosis, and lysosomal integrity.
Main Methods:
- Human colon cancer metastatic cells (SW620) were treated with procyanidins and various lysosomotropic compounds.
- Cell growth, apoptosis induction, and lysosomal membrane permeability were assessed using established methodologies.
Main Results:
- Lysosomotropic drugs (MDL 72527, phenylalanine methylester, chloroquine) significantly enhanced procyanidin-induced growth inhibition and apoptosis in SW620 cells.
- These synergistic effects were observed at non-cytotoxic concentrations of the lysosomotropic compounds.
- The enhanced anti-cancer activity was primarily attributed to increased lysosomal membrane permeability.
Conclusions:
- Combining non-toxic concentrations of lysosomotropic compounds with apple procyanidins potentiates their anti-carcinogenic properties.
- This combination strategy offers a promising approach for enhancing the efficacy of procyanidin-based colon cancer chemoprevention.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Lysosomes
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
